Let’s look at the key reasons that are pushing Galmed Pharmaceuticals Ltd (GLMD) to new highs

On November 20, 2023, Galmed Pharmaceuticals Ltd (NASDAQ: GLMD) opened at $0.405, higher 6.68% from the last session. During the day, the shares moved up to $0.4343 and dropped to $0.405 before settling in for the closing price of $0.41. Price fluctuations for GLMD have ranged from $0.35 to $14.18 over the past 52 weeks.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -2.43%. With a float of $3.55 million, this company’s outstanding shares have now reached $3.81 million.

Considering the fact that the conglomerate employs 20 people, you should pay attention to its efficiency factor.

Galmed Pharmaceuticals Ltd (GLMD) Breakdown of a Key Holders of the stock

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Galmed Pharmaceuticals Ltd is 6.88%, while institutional ownership is 17.38%.

Galmed Pharmaceuticals Ltd (GLMD) Recent Fiscal highlights

If we go through the results of last quarter, which was made public on 6/29/2023, the company posted -$0.95 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.34) by -$0.61. This company achieved a return on equity of -81.36. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.

For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.00% during the next five years compared to 6.23% growth over the previous five years of trading.

Galmed Pharmaceuticals Ltd (NASDAQ: GLMD) Trading Performance Indicators

Check out the current performance indicators for Galmed Pharmaceuticals Ltd (GLMD). In the past quarter, the stock posted a quick ratio of 3.59.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.79

Technical Analysis of Galmed Pharmaceuticals Ltd (GLMD)

Compared to the last year’s volume of 0.12 million, its volume of 0.71 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 65.97%. Additionally, its Average True Range was 0.04.

During the past 100 days, Galmed Pharmaceuticals Ltd’s (GLMD) raw stochastic average was set at 1.64%, which indicates a significant decrease from 72.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 85.93% in the past 14 days, which was lower than the 102.36% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.4817, while its 200-day Moving Average is $3.3252. Nevertheless, the first resistance level for the watch stands at $0.4441 in the near term. At $0.4538, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.4734. If the price goes on to break the first support level at $0.4148, it is likely to go to the next support level at $0.3952. Now, if the price goes above the second support level, the third support stands at $0.3855.

Galmed Pharmaceuticals Ltd (NASDAQ: GLMD) Key Stats

There are currently 1,680K shares outstanding in the company with a market cap of 1.65 million. Presently, the company’s annual sales total 0 K according to its annual income of -17,870 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -1,590 K.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Wearable Devices (WLDS) Stock Rose 12% On Tuesday, But On What Basis?

Wearable Devices Ltd (NASD: WLDS) is experiencing significant growth...

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

HashiCorp Inc (HCP) last year’s performance of -14.87% is a clear signal for an entertaining trading season.

On November 24, 2023, HashiCorp Inc (NASDAQ: HCP) opened at $20.87, higher 1.96% from the last session. During the day, the shares moved up...

Kyndryl Holdings Inc (KD) is ready for next Episode as it posted an annual sales of 17,026 M

A new trading day began on November 24, 2023, with Kyndryl Holdings Inc (NYSE: KD) stock priced at $18.05, down -0.39% from the previous...

Atmos Energy Corp. (ATO) is expecting -4.84% growth in the next quarter: What can investors do to maximize their returns?

Atmos Energy Corp. (NYSE: ATO) kicked off on November 24, 2023, at the price of $112.31, down -0.93% from the previous trading day. During...


Please enter your comment!
Please enter your name here